Does SURUFATINIB Cause Myelosuppression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Myelosuppression have been filed in association with SURUFATINIB. This represents 37.5% of all adverse event reports for SURUFATINIB.
6
Reports of Myelosuppression with SURUFATINIB
37.5%
of all SURUFATINIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Myelosuppression From SURUFATINIB?
Of the 6 reports, 2 (33.3%) required hospitalization.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SURUFATINIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SURUFATINIB Cause?
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)